MultiPoint Pacing™ Post Market Study
MultiPoint Pacing™ Post Market Study
This is a prospective, multicenter, non-randomized registry/observational study. The study will enroll up to 2,000 patients with successful St. Jude Medical (SJM) Cardiac Resynchronization Therapy (CRT) MP device implant from up to 140 centers undergoing CRT implantation.
Any patient who received a market approved SJM Quadra Allure MP, Quadra Assura MP, or newer SJM CRT MP device is eligible for enrollment in the study. MultiPoint Pacing (MPP) programming guidance will be specified in the protocol. Patients will be followed for 12 months after implant. Data will be collected at Baseline (within 30 days prior to implant), Post-Implant (within 30 days following successful CRT device implant), 3, 6, 12 months and during any unscheduled follow-up visit.
Inclusion Criteria:
Exclusion Criteria:
Kingsport, Tennessee 37660, United States
Wauwatosa, Wisconsin 53226, United States
Caba, Buenos Aires C1122AAL, Argentina
Bogota, Antioquia 110111, Colombia
Shinjuku-Ku, Tokyo 1628666, Japan